Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Juvenile dermatomyositis. Pathophysiology and disease expression

L M Pachman1

  • 1Department of Pediatrics, Northwestern University Medical School, Illinois, USA.

Pediatric Clinics of North America
|October 1, 1995
PubMed
Summary

Children with juvenile dermatomyositis (JDMS) symptoms like rash, muscle weakness, or fatigue need prompt medical attention. Advances in therapy can improve outcomes, and research is ongoing to understand JDMS disease factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide association study identifies HLA 8.1 ancestral haplotype alleles as major genetic risk factors for myositis phenotypes.

Genes and immunity·2015
Same author

The economic impact of intermittent high-dose intravenous versus oral corticosteroid treatment of juvenile dermatomyositis.

Arthritis care and research : the official journal of the Arthritis Health Professions Association·2003
Same author

Juvenile dermatomyositis: the association of the TNF alpha-308A allele and disease chronicity.

Current rheumatology reports·2001
Same author

Expression of TNFalpha by muscle fibers in biopsies from children with untreated juvenile dermatomyositis: association with the TNFalpha-308A allele.

Clinical immunology (Orlando, Fla.)·2001
Same author

TNFalpha-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications.

Arthritis and rheumatism·2000
Same author

Decreased levels of CD54 (ICAM-1)-positive lymphocytes in the peripheral blood in untreated patients with active juvenile dermatomyositis.

Clinical and diagnostic laboratory immunology·2000

Area of Science:

  • Pediatric Rheumatology
  • Immunology
  • Genetics

Background:

  • Juvenile dermatomyositis (JDMS) and polymyositis (PM) are idiopathic inflammatory myopathies affecting children and adults.
  • While sharing some clinical features, their distinct pathophysiologies are not fully elucidated.
  • Early diagnosis and management are crucial for mitigating long-term complications.

Purpose of the Study:

  • To summarize current understanding of JDMS and PM.
  • To highlight the importance of prompt medical care for symptomatic children.
  • To underscore the need for further research into the epidemiology and genetics of JDMS.

Main Methods:

  • Literature review and synthesis of existing data on JDMS and PM.
  • Analysis of clinical presentation and therapeutic advancements.

Related Experiment Videos

  • Discussion of ongoing national research efforts.

    • Main Results:

    • Specific symptoms like rash, proximal muscle weakness, and fatigue warrant immediate medical evaluation in children.
    • Current physical and medical therapies can significantly ameliorate disease consequences.
    • Preliminary data suggest differing pathophysiologies between JDMS and PM, requiring further investigation.

    Conclusions:

    • Prompt medical attention is vital for children presenting with JDMS symptoms.
    • Therapeutic interventions offer improved prognoses for affected children.
    • Further research into the epidemiologic and genetic factors influencing JDMS susceptibility and severity is essential.